Phase I Trial of Arginine Deprivation Therapy with ADI-PEG 20 Plus Docetaxel in Patients with Advanced Malignant Solid Tumors.

Clinical cancer research : an official journal of the American Association for Cancer Research2015Tomlinson BK, Thomson JA, Bomalaski JS, et al.

Study designOther primary literature

SubjectHuman

Record checks

Study design: Other primary literature
Subject: Human
Publication year: 2015
Source: doi.org
Abstract display: Not reproduced here
Publication status: Active
Status checked: 17 Aug 2026
Collected: 13 Aug 2026
Freshness: Current
Review stage: Automated
Record status: Published

How to read this record →

Abstract

cc by 以外（cc by-nc / cc by-nc-nd / NONE 等）は抄録を再掲しない。DOI/PMID へのリンクのみ表示する。

MeSH

Antineoplastic Combined Chemotherapy ProtocolsArginineDocetaxelDrug Administration ScheduleDrug-Related Side Effects and Adverse ReactionsFemaleHumansHydrolasesMaleNeoplasm StagingNeoplasmsPolyethylene GlycolsTaxoidsTreatment Outcome

DOI 10.1158/1078-0432.ccr-14-2610

PMID 25739672

View source →